Premium
Perivascular epithelioid cell tumor of the uterus: Immunohistochemical, ultrastructural and molecular study
Author(s) -
Park SungHye,
Ro Jae Y.,
Kim HanSeong,
Lee Eung Soo
Publication year - 2003
Publication title -
pathology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
eISSN - 1440-1827
pISSN - 1320-5463
DOI - 10.1046/j.1440-1827.2003.01557.x
Subject(s) - perivascular epithelioid cell , cd117 , pathology , epithelioid cell , vimentin , angiomyolipoma , cd34 , progesterone receptor , biology , desmin , immunohistochemistry , estrogen receptor , stem cell , medicine , microbiology and biotechnology , endocrinology , kidney , genetics , cancer , breast cancer
A case of perivascular epithelioid cell tumor of the uterus is reported, occurring in a 32‐year‐old woman. The tumor (8.0 cm in dimension) showed exophytic growth from the outer half of the myometrium. Histopathologically, the tumor was composed of thick blood vessels and perivascular epithelioid cells. The neoplastic cells were strongly immunoreactive for HMB45 antigen, CD117 (c‐kit), vimentin and the progesterone receptor, but completely negative for S‐100 protein, smooth muscle actin, desmin, CD34, the estrogen receptor and p16. The Ki‐67 labeling index was low (1.25%). Ultrastructurally, the neoplastic cells had numerous premelanosomes with some glycogen deposits. Single‐stranded DNA conformational polymorphism of p53 and methylation‐specific polymerase chain reaction of p16 revealed negative results. Definite melanosomes on electron microscopic analysis and coexpression of HMB45 antigen and stem cell factor receptor (CD117) may provide the clue to understanding perivascular epithelioid cell tumor because angiomyolipoma also coexpresses HMB45 antigen and CD117.